Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate/vilanterol safety in asthma
NCT01018186Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of fluticasone furoate + vilanterol in asthma, sponsored by GSK. Started Oct 2009; status: completed.
02
Drugs
fluticasone furoate + vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01018186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018186.